Exhibit 03 - FDA Untitled Letter Misleading Efficacy Claims CMS 665089 (Nov. 20 2023)

NonrulemakingSupporting & Related MaterialFDA-2026-P-6249-0005
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 3, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets